Fosun International’s Infinity Pharmaceuticals, Inc. INFI Stock Holding History

Fosun International’s Portfolio INFI Stock Details INFI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-418,296	Closed	-$728K	–	304
2019 Q2	$728K	Hold	418,296	–	–	0.05%	197
2019 Q1	$786K	Buy	418,296 +40,000	+11%	+$58.5K	0.05%	182
2018 Q4	$424K	Buy	378,296 +19,437	+5%	+$35K	0.03%	232
2018 Q3	$879K	Buy	+358,859	New	+$742K	0.04%	151

Other funds holding INFI

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

PIM

Platinum Investment Management Sydney Australia 2000, Australia $397M AUM 63.96% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

BCM

Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

Fosun International's INFI Position: Q3 2019 in Review

Fosun International sold out of Infinity Pharmaceuticals, Inc. (INFI) in Q3 2019, closing a stake of 418,296 shares — an estimated $728K sold.

Fosun International first reported a position in INFI in Q3 2018 and held it in 4 quarters. The position peaked at $879K in Q3 2018. 51 funds tracked by Wall St. Rank hold INFI as of Q3 2019.

Fosun International reported no remaining Infinity Pharmaceuticals, Inc. position as of Q3 2019 after selling out during the quarter.
Fosun International sold 418,296 Infinity Pharmaceuticals, Inc. shares in Q3 2019, an estimated $728K.
Fosun International first reported a position in Infinity Pharmaceuticals, Inc. in Q3 2018 and held it in 4 quarters.
Fosun International's Infinity Pharmaceuticals, Inc. position peaked at $879K in Q3 2018.
51 funds tracked by Wall St. Rank held Infinity Pharmaceuticals, Inc. as of Q3 2019.

Based on Fosun International's 13F filing for Q3 2019, filed 12 Nov 2019.